Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7073280 | 1.00 | SMN1; SMN2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL74754 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1337777 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL5276199 | 1.00 | SMN1; SMN2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL159222 | 1.00 | — | — | |
| SCHEMBL186262 | 0.97 | — | — | |
| SCHEMBL159223 | 0.97 | — | — | |
| SCHEMBL47274 | 0.97 | — | — | |
| SCHEMBL2236696 | 0.95 | — | — | |
| Methylene Chloride SCHEMBL29028670 | 0.93 | KIF11 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1081 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119409588-A | Caffeoyl amino acid methyl ester derivative and preparation method and application thereof | 西北大学 | 2025-02-11 | — | — | CN | claimed |
| CN-117142978-A | Preparation method of benserazide hydrochloride and application of benserazide hydrochloride in composition | 重庆圣华曦药业股份有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-113912524-B | Polypeptide compound containing sulfur amide and synthesis method thereof | 华东师范大学 | 2023-12-01 | — | — | CN | claimed |
| CN-113527399-B | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-113912524-A | Polypeptide compound containing sulfamide and synthesis method thereof | 华东师范大学 | 2022-01-11 | — | — | CN | claimed |
| CN-113527399-A | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-110105347-B | 2- (2-pyridyl) -1, 3-oxazole amide derivative and preparation method and application thereof | 浙江工业大学 | 2021-01-15 | — | — | CN | claimed |
| CN-108707115-B | Synthetic method of acrylic acid derivative | 成都道合尔医药技术有限公司 | 2020-09-01 | — | — | CN | claimed |
| CN-110105347-A | A kind of 2- (2- pyridyl group) -1,3- oxazole amide derivatives and its preparation method and application | 浙江工业大学 | 2019-08-09 | — | — | CN | claimed |
| CN-109265370-A | Preparation method of N- (9-fluorenylmethoxycarbonyl) -O-tert-butyl-L-serine | 四川什邡市三高生化实业有限公司 | 2019-01-25 | — | — | CN | claimed |
| US-20130041180-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN LABORATORIES PRIVATE LIMITED (IN) | 2013-02-14 | — | — | US | claimed |
| EP-2534127-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN Laboratories Limited (IN) | 2012-12-19 | — | — | EP | claimed |
| CN-101284803-B | Synthetic method of N-fluorenylmethoxycarbonyl-O-tert-butyl serine | GL BIOCHEM SHANGHAI LTD | 2012-01-04 | — | — | CN | claimed |
| WO-2011099033-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN LABORATORIES LIMITED (IN) | 2011-08-18 | — | — | WO | claimed |
| CN-101284803-A | Synthetic method of N-fluorenylmethoxycarbonyl-O-tert-butyl serine | GL BIOCHEM SHANGHAI LTD (CN) | 2008-10-15 | — | — | CN | claimed |
| EP-1907503-A1 | CORROSION INHIBITOR OR INTENSIFIER FOR USE IN ACIDIZING TREATMENT FLUIDS | Halliburton Energy Services, Inc. (US) | 2008-04-09 | — | — | EP | claimed |
| CN-1329403-C | A method for preparing N-acyl lysophosphatidylcholine compound and a pharmaceutical composition containing the compound for treating metabolic bone disease | JHON GIL JA (KR) | 2007-08-01 | — | — | CN | claimed |
| WO-2007007025-A1 | CORROSION INHIBITOR OR INTENSIFIER FOR USE IN ACIDIZING TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2007-01-18 | — | — | WO | claimed |
| US-20070010404-A1 | Corrosion inhibitor or intensifier for use in acidizing treatment fluids | HALLIBURTON ENERGY SERVICES, INC. | 2007-01-11 | — | — | US | claimed |
| CN-1608073-A | A method for preparing N-acyl lysophosphatidylcholine compound and a pharmaceutical composition containing the compound for treating metabolic bone disease | JHON GIL JA (KR) | 2005-04-20 | — | — | CN | claimed |